Healthcare Services

Facility expansions and technological advancements are shaping the biosimilar testing services market

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Biosimilar Testing Services Market During 2026–2030?

The scale of the biosimilar testing services market has expanded significantly over the past few years. This market is projected to expand from $1.84 billion in 2025 to reach $2.08 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.0%. Historically, this growth can be ascribed to several factors, including the widening of biosimilar development pipelines, a rise in regulatory clearances for biosimilars, the expansion of biologics production, an increasing dependence on CRO testing services, and advancements in analytical testing methodologies.

The biosimilar testing services market size is anticipated to undergo significant expansion in the coming years, with projections indicating a rise to $3.37 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period is fueled by the escalating demand for cost-effective biologic alternatives, the widening reach of global biosimilar markets, the increasing intricacy of biologic molecules, a heightened focus on comparability studies, and growing investments in biosimilar R&D. Prominent trends for this period include an increasing requirement for comprehensive analytical characterization, the growing adoption of advanced bioanalytical assays, a stronger emphasis on regulatory-compliant testing services, the expansion of outsourced support for biosimilar development, and an enhanced focus on method validation and consistency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biosimilar-testing-services-global-market-report

What Key Factors Are Shaping The Biosimilar Testing Services Market Landscape?

The expanding occurrence of autoimmune diseases is anticipated to drive the growth of the biosimilar testing services market moving forward. Autoimmune diseases are conditions where the body’s immune system mistakenly attacks its own healthy cells and tissues, leading to inflammation and tissue damage. This increasing prevalence is attributed to the rising need for effective biologic treatments that can manage chronic symptoms, reduce flare-ups, and improve long-term patient outcomes. Biosimilar testing services support the management of autoimmune diseases by ensuring biosimilars are safe, effective, and comparable to original biologics, thus helping to provide affordable and accessible therapeutic options. For instance, in February 2024, Arthritis Australia, an Australia-based non-profit organization, estimated that 562,378 Australians would be living with RA in 2025, representing 14% of all arthritis cases for that year. By 2040, this figure is projected to increase by 33% to 748,721 people. This signifies an increase of 186,343 Australians with RA when compared to 2025. Therefore, the rising prevalence of autoimmune diseases is a key driver for the growth of the biosimilar testing services market.

How Is The Biosimilar Testing Services Market Categorized Across Its Segment Groups?

The biosimilar testing services market covered in this report is segmented –

1) By Service Type: Analytical Testing, Bioanalytical Testing, Stability Testing, Method Development And Validation, Other Service Types

2) By Technology: Cell-Based Assays, Chromatography Techniques, Mass Spectrometry, Bioassays

3) By Molecule Type: Monoclonal Antibodies, Recombinant Hormones, Insulin, Interferons, Enzymes, Other Molecule Types

4) By Application: Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Government Agencies

Subsegments:

1) By Analytical Testing: Protein Characterization, Impurity Profiling, Potency Testing, Glycosylation Analysis, Structural Analysis

2) By Bioanalytical Testing: Pharmacokinetics Analysis, Immunogenicity Testing, Biomarker Analysis, Drug Concentration Measurement, Toxicokinetics Testing

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Testing, Photostability Testing, Temperature Cycling Studies

4) By Method Development And Validation: Analytical Method Development, Bioanalytical Method Development, Method Validation, Process Validation, Assay Development

5) By Other Service Types: Immunogenicity Assessment, Formulation Development, Microbial Testing, Release Testing, Regulatory Consulting

What Market Trends Are Affecting The Biosimilar Testing Services Market?

Key companies in the biosimilar testing services market are concentrating on enlarging their facilities to incorporate new technologies or capabilities, thereby improving productivity and market standing. Facility expansion entails increasing or modernizing existing physical spaces or infrastructure to support growing operational requirements or future development. For example, in October 2023, Tanvex BioPharma USA Inc., a US-based biotechnology company, unveiled Tanvex CDMO. This cutting-edge contract development and manufacturing organization, situated in San Diego, provides comprehensive biologics development and manufacturing solutions, including cell line development, process optimization, analytical testing, and regulatory assistance. The goal of this new facility is to accelerate the progress of biopharmaceutical products from early stages to commercial production, leveraging advanced technologies and expert teams to deliver groundbreaking and life-altering biologics to patients globally.

Which Firms Are Influencing Competition In The Biosimilar Testing Services Market?

Major companies operating in the biosimilar testing services market are Thermo Fisher Scientific Inc., IQVIA Laboratories, Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Intertek Group plc, Samsung Biologics Co. Ltd., Almac Group Limited, Syngene International Limited, Shanghai Medicilon Inc., Kymos Group S.L., Pacific BioLabs Inc., Profacgen Inc., ExcellGene SA, BioPharmaSpec Ltd., Charles River Laboratories International Inc., Covance Inc., PPD Inc., ICON plc, Parexel International Corporation, Frontage Laboratories Inc.

Get The Full Biosimilar Testing Services Market Report:

https://www.thebusinessresearchcompany.com/report/biosimilar-testing-services-global-market-report

Which Region Is The Top Contributor To The Biosimilar Testing Services Market By Share?

North America was the largest region in the biosimilar testing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimilar testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biosimilar Testing Services Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biosimilar-testing-services-global-market-report

Browse Through More Reports Similar to the Global Biosimilar Testing Services Market 2026, By The Business Research Company

Technical Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Insulation Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulation-products-global-market-report

Aircraft Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/aircraft-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795